Proposed LCD DL40429: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — Palmetto GBA
Oncology
Government source· CMS / MACverify ↗HCPCS Level II code
$46.76
2026 Physician Fee Schedule · non-facility
Source: CMS Physician Fee Schedule (PPRRVU 2026). CMS fee schedules ↗ · PFS status indicator A
National amount before geographic adjustment. Your MAC's locality rate will differ.
Code definition
Code
G0452
Code system
HCPCS Level II
Full description
Molecular pathology procedure; physician interpretation and report
CLV Intelligence is tracking 2 policy changes that cite HCPCS G0452 between 2026-06-05 and 2026-08-27, drawn from 1 LCD/NCD coverage update and 1 proposed LCD. The changes span Oncology. 1 is flagged critical or high priority.
Counts reflect the source documents CLV has matched to HCPCS G0452 to date; each links to the government publication that is authoritative. Monitored daily from CMS, the Federal Register, and Medicare Administrative Contractor publications.
Recent policy changes matched to G0452
Matched to this code by CLV analysis of each policy. The linked source document is authoritative.
Oncology
Government source· CMS / MACverify ↗Search G0452 across all alerts
Full history of CMS and MAC policy changes matched to this code.
Audit documentation
The Tripwire Audit Pack exports 12 months of single-specialty policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get alerts when policy changes affect G0452
Free weekly digest — no subscription required.
Get the free 90-day policy snapshot for your specialty
Get a free 90-day sample snapshot — a PDF of every CMS and MAC policy change we tracked for your specialty and jurisdiction in the last quarter. Delivered instantly.
By downloading, you agree to receive related policy update emails. You can unsubscribe at any time. Privacy policy